Several brain-targeting chemical delivery systems (CDS) based on a dihydropyridine ⇌ pyridinium salt-type targetor were synthesized and evaluated for LY231617 (1), a di-tert-butylated phenolic amine antioxidant with potential use in the treatment of brain injuries. The dihydropyridine moiety was chemically attached to the amine (by either amide or various substituted carbamate linkages) or to the phenolic hydroxyl (by carboxylic ester linkage) functionalities of LY231617. In vitro stability and in vivo tissue distribution studies (in the rat) were performed with the novel derivatives. The results indicated that a simple amide-type CDS demonstrated efficient delivery of LY231617-targetor conjugate to the CNS. This derivative which contains the intact pharmacophore might possess intrinsic pharmacological antioxidant activity. Favorable in vitro properties suggested that a substituted carbamate-type CDS might be a better delivery modality for LY231617.